Clinical Trial Update: LYell SYndrome MEsenchymal Stromal Cells Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating adipose-derived mesenchymal stromal cells for Lyell syndrome/toxic epidermal necrolysis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyell Syndrome
• Overlap Syndrome
• Toxic Epidermal Necrolysis

Drugs mentioned

• Adipose-derived mesenchymal stromal cells (adipose-derived mesenchymal stromal cells)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Epidermal Necrolysis, Lyell Syndrome | Phase 1, Phase 2 | Status: RECRUITING